These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3714345)

  • 21. Changes in airflow obstruction and oxygen saturation in response to exercise and bronchodilators in cystic fibrosis.
    Macfarlane PI; Heaf D
    Pediatr Pulmonol; 1990; 8(1):4-11. PubMed ID: 2405343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchial measurement with three-dimensional quantitative thin-section CT in patients with cystic fibrosis.
    Montaudon M; Berger P; Cangini-Sacher A; de Dietrich G; Tunon-de-Lara JM; Marthan R; Laurent F
    Radiology; 2007 Feb; 242(2):573-81. PubMed ID: 17179399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obstruction of the respiratory pathways, its evaluation by methods of functional examination of the lungs and development in patients with cystic fibrosis.
    Houstĕk J; Zapletal A; Samánek M; Vávrová V
    Czech Med; 1979; 2(1-2):1-10. PubMed ID: 527420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchial hyperreactivity in cystic fibrosis and asthma.
    Mitchell I; Corey M; Woenne R; Krastins IR; Levison H
    J Pediatr; 1978 Nov; 93(5):744-8. PubMed ID: 712474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between different methods for detecting bronchial hyperreactivity. Bronchial hyperreactivity: methods of study.
    Grassi C; Casali L; Rossi A; Rampulla C; Zanon P; Cerveri I; Mastroberardino M
    Eur J Respir Dis Suppl; 1980; 106():19-27. PubMed ID: 6937352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphometric Analysis of Explant Lungs in Cystic Fibrosis.
    Boon M; Verleden SE; Bosch B; Lammertyn EJ; McDonough JE; Mai C; Verschakelen J; Kemner-van de Corput M; Tiddens HA; Proesmans M; Vermeulen FL; Verbeken EK; Cooper J; Van Raemdonck DE; Decramer M; Verleden GM; Hogg JC; Dupont LJ; Vanaudenaerde BM; De Boeck K
    Am J Respir Crit Care Med; 2016 Mar; 193(5):516-26. PubMed ID: 26551917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic fibrosis.
    van Haren EH; Lammers JW; Festen J; van Herwaarden CL
    Eur Respir J; 1992 Oct; 5(9):1083-8. PubMed ID: 1426217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of inhomogeneity of lung units to the maximal expiratory flow-volume curve in children with asthma and cystic fibrosis.
    Landau LI; Taussig LM; Macklem PT; Beaudry PH
    Am Rev Respir Dis; 1975 Jun; 111(6):725-31. PubMed ID: 1137240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproducibility of hyperventilation of cold dry air in children with cystic fibrosis.
    Chay OM; Sly PD; Olinsky A
    Aust N Z J Med; 1986 Oct; 16(5):644-7. PubMed ID: 3469961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled lignocaine does not alter bronchial hyperresponsiveness to hyperventilation of dry cold air in asthmatic subjects.
    Caire N; Cartier A; Ghezzo H; L'Archevêque J; Malo JL
    Clin Exp Allergy; 1989 Jan; 19(1):65-70. PubMed ID: 2702512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral airway involvement in asthma assessed by single-breath SF6 and He washout.
    Gustafsson PM; Ljungberg HK; Kjellman B
    Eur Respir J; 2003 Jun; 21(6):1033-9. PubMed ID: 12797500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thoracoabdominal asynchrony and ratio of time to peak tidal expiratory flow over total expiratory time in adolescents with cystic fibrosis.
    Hunter JM; Sperry EE; Ravilly S; Colin AA
    Pediatr Pulmonol; 1999 Sep; 28(3):199-204. PubMed ID: 10495337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth failure in cystic fibrosis.
    McNaughton SA; Stormont DA; Shepherd RW; Francis PW; Dean B
    J Paediatr Child Health; 1999 Feb; 35(1):86-92. PubMed ID: 10234643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Airway responsiveness to hyperosmolar saline challenge in cystic fibrosis: a pilot study.
    Rodwell LT; Anderson SD
    Pediatr Pulmonol; 1996 May; 21(5):282-9. PubMed ID: 8726153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchial reactivity in cystic fibrosis with normal pulmonary function.
    Van Asperen P; Mellis CM; South RT; Simpson SJ
    Am J Dis Child; 1981 Sep; 135(9):815-9. PubMed ID: 7282657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory muscle function in patients with cystic fibrosis.
    Dassios T; Katelari A; Doudounakis S; Mantagos S; Dimitriou G
    Pediatr Pulmonol; 2013 Sep; 48(9):865-73. PubMed ID: 23143864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to inhaled bronchodilators and nonspecific airway hyperreactivity in children with cystic fibrosis.
    Sanchez I; Powell RE; Chernick V
    Pediatr Pulmonol; 1992 Sep; 14(1):52-7. PubMed ID: 1437344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Area under the maximum expiratory flow-volume curve--a sensitive parameter in the evaluation of airway patency.
    Zapletal A; Hladíková M; Chalupová J; Svobodová T; Vávrová V
    Respiration; 2008; 75(1):40-7. PubMed ID: 17299253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transit time analysis of the forced expiratory vital capacity in cystic fibrosis.
    Neuburger N; Levison H; Kruger K
    Am Rev Respir Dis; 1976 Oct; 114(4):753-9. PubMed ID: 970749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trapped gas and airflow limitation in children with cystic fibrosis and asthma.
    Desmond KJ; Coates AL; Martin JG; Beaudry PH
    Pediatr Pulmonol; 1986; 2(3):128-34. PubMed ID: 3737274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.